By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
FDA Curcumin Investigation Supports Imprimis (immy) Statement 9/14/2017 11:06:49 AM
Imprimis (immy) Releases Statement Regarding Allergan (AGN) Lawsuit 9/11/2017 8:55:44 AM
Allergan (AGN) Files Suits Against Imprimis (immy), Prescriber's Choice, Inc., And Sincerus Florida, LLC 9/8/2017 7:26:08 AM
Imprimis (immy) Announces Second Quarter 2017 Financial Results 8/11/2017 11:26:14 AM
Imprimis (immy) Stock Down in Response to FDA Inquiry for Curcumin Emulsion 8/7/2017 10:36:11 AM
Imprimis (immy) To Host Its Second Quarter 2017 Financial Report Conference Call And Webcast On August 10, 2017 At 4:15 P.M. EDT 7/31/2017 1:33:28 PM
Imprimis (immy) Patent-Pending Dropless And LessDrops Formulations Exceed One Million Patient Eyes Milestone 7/27/2017 6:46:59 AM
Imprimis (immy) Announces $16 Million Debt Facility With SWK Holdings 7/20/2017 6:53:02 AM
Imprimis (immy) Sells Pennsylvania Facility And Sinus Assets 6/29/2017 9:38:19 AM
Imprimis (immy) Announces First Quarter 2017 Financial Results 5/11/2017 8:34:27 AM